Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Under Armour Inc (Class A) | Kevin A. Plank | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 2,123,894 | 2,412,824 (1%) | 0% | 0 | Class C Common Stock | |
| Golub Cap BDC Inc | David B. Golub | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 1,780,496 | 3,477,233 (2%) | 1% | - | Common Stock, par value $0.001 per share | |
| Golub Cap BDC Inc | Lawrence E. Golub | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 1,780,496 | 3,477,233 (2%) | 1% | - | Common Stock, par value $0.001 per share | |
| Golub Cap BDC Inc | David B. Golub | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 1,676,387 | 1,676,387 (1%) | 1% | - | Common Stock, par value $0.001 per share | |
| Golub Cap BDC Inc | Lawrence E. Golub | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 1,676,387 | 1,676,387 (1%) | 1% | - | Common Stock, par value $0.001 per share | |
| Lesaka Tech Inc | Ali Haeri Mazanderani | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 1,000,000 | 1,000,000 | - | - | Employee stock option (right to buy) | |
| Lesaka Tech Inc | Ali Haeri Mazanderani | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 1,000,000 | 1,000,000 | - | - | Employee stock option (right to buy) | |
| Lesaka Tech Inc | Ali Haeri Mazanderani | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 1,000,000 | 1,000,000 | - | - | Employee stock option (right to buy) | |
| Lesaka Tech Inc | Ali Haeri Mazanderani | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 1,000,000 | 1,000,000 | - | - | Employee stock option (right to buy) | |
| Mangoceuticals Inc | Jacob D. Cohen | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 800,000 | 800,000 | - | 0 | Common Stock | |
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 54.75 per share. | 03 Jun 2024 | 691,525 | 3,340,018 | - | 54.8 | 37,860,994 | Common Stock |
| Janux Therapeutics Inc | Tighe Reardon | Acting Chief Financial Officer | 03 Jun 2024 | 691,525 | 3,340,018 | - | 54.8 | 37,860,994 | Common Stock | |
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 54.75 per share. | 03 Jun 2024 | 677,279 | 3,271,216 | - | 54.7 | 37,081,025 | Common Stock |
| Garmin | Jonathan C. Burrell | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 650,000 | 651,700 (0%) | 0% | 0 | Registered Shares | |
| Garmin | Jonathan C. Burrell | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 650,000 | 7,199,847 (3%) | 0% | 0 | Registered Shares | |
| ACV Auctions Inc (Class A) | William R. Zerella | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 631,239 | 744,136 | - | - | Class B Common Stock | |
| ACV Auctions Inc (Class A) | William R. Zerella | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 631,239 | 225,000 | - | - | Employee Stock Option (Right to Buy) | |
| Vodafone Grp PLC (ADR) | Luka Mucic | None | 03 Jun 2024 | 510,000 | 8,790,854 (0%) | 0% | 0.8 | 388,365 | Ords 0.21p | |
| AlTi Global Inc (Class A) | Michael Tiedemann | Director, Chief Executive Officer | 03 Jun 2024 | 458,733 | 458,733 | - | - | Peformance Restricted Stock Unit | ||
| Digital Turbine Inc | Michael Akkerman | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 428,571 | 428,571 (0%) | 0% | 0 | Common Stock | |
| Salesforce | G. Mason Morfit | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 233.17 per share. | 03 Jun 2024 | 428,000 | 3,914,309 (0%) | 0% | 233.2 | 99,796,760 | Common Stock |
| Sera Prognostics Inc (Class A) | Joshua Phillips | Director | Other type of transaction at price $ 0.00 per share. | 03 Jun 2024 | 381,869 | 6,753 | - | 0 | Class A Common Stock | |
| Sera Prognostics Inc (Class A) | Joshua Phillips | Director | Other type of transaction at price $ 0.00 per share. | 03 Jun 2024 | 356,660 | 17,684 | - | 0 | Class A Common Stock | |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 347,939 | 435,420 (0%) | 0% | 0 | Common Stock | |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 347,939 | 347,938 | - | - | Performance Stock Unit | |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 281,830 | 0 (0%) | 0% | 0 | Common Stock | |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 281,830 | 852,987 (0%) | 0% | 0 | Common Stock | |
| Ingersoll Rand | Vicente Reynal | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.61 per share. | 03 Jun 2024 | 258,488 | 358,855 (0%) | 0% | 10.6 | 2,742,558 | Common Stock |
| Ingersoll Rand | Vicente Reynal | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 258,488 | 198,486 | - | - | Stock Options (Right to Buy) | |
| Tesla | James R. Murdoch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.31 per share. | 03 Jun 2024 | 250,020 | 250,020 (0%) | 0% | 21.3 | 5,327,926 | Common Stock |
| Tesla | James R. Murdoch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 250,020 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| TaskUs Inc (Class A) | Bryce Maddock | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 240,000 | 240,000 | - | - | Restricted Stock Units | |
| ChargePoint Holdings Inc (Class A) | Jagdeep CA. Singh | CCXO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 236,250 | 895,753 | - | - | Common Stock | |
| Bionano Genomics Inc | R. Erik Holmlin | Director, PRESIDENT AND CEO | 03 Jun 2024 | 204,000 | 204,000 | - | - | Stock Option (Right to Buy) | ||
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 200,000 | 430,000 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 200,000 | 0 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 200,000 | 230,000 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 200,000 | 0 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Ingersoll Rand | Vicente Reynal | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 198,486 | 0 | - | - | Stock Options (Right to Buy) | |
| Ingersoll Rand | Vicente Reynal | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.61 per share. | 03 Jun 2024 | 198,486 | 298,853 (0%) | 0% | 10.6 | 2,105,936 | Common Stock |
| Barinthus Biotherapeutics PLC. (ADR) | Leon Hooftman | Chief Medical Officer | 03 Jun 2024 | 195,166 | 195,166 | - | - | Share Option (Right to Buy) | ||
| ChargePoint Holdings Inc (Class A) | Rebecca Chavez | CLO and Corp Secretary | 03 Jun 2024 | 189,000 | 971,690 | - | - | Common Stock | ||
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.68 per share. | 03 Jun 2024 | 178,667 | 256,753 (0%) | 0% | 15.7 | 2,801,499 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Jagdeep CA. Singh | CCXO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 175,000 | 659,503 | - | - | Common Stock | |
| AlTi Global Inc (Class A) | Michael Tiedemann | Director, Chief Executive Officer | 03 Jun 2024 | 173,729 | 173,729 | - | - | Restricted Stock Units | ||
| Ingersoll Rand | Vicente Reynal | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 89.56 per share. | 03 Jun 2024 | 166,547 | 192,308 (0%) | 0% | 89.6 | 14,916,616 | Common Stock |
| Coya Therapeutics Inc | Howard Berman | Director, Chief Executive Officer | 03 Jun 2024 | 163,663 | 163,663 | - | - | Stock Option (right to buy) | ||
| Sera Prognostics Inc (Class A) | Joshua Phillips | Director | Other type of transaction at price $ 0.00 per share. | 03 Jun 2024 | 156,332 | 9,766 | - | 0 | Class A Common Stock | |
| Kyndryl Holdings Inc | Martin J. Schroeter | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 152,059 | 1,435,739 | - | 0 | Common Stock | |
| Datadog Inc (Class A) | Olivier Pomel | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 150,240 | 1,802,880 | - | - | Stock Option (Right to Buy) | |
| Datadog Inc (Class A) | Olivier Pomel | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 150,240 | 8,883,527 | - | - | Class B Common Stock | |
| Coherent Corp | James Robert Anderson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 147,214 | 147,214 (0%) | 0% | 0 | Common Stock | |
| BigBear.ai Holdings Inc | Pamela Braden | Director | Purchase of securities on an exchange or from another person at price $ 1.49 per share. | 03 Jun 2024 | 140,939 | 446,396 | - | 1.5 | 209,999 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Rebecca Chavez | CLO and Corp Secretary | 03 Jun 2024 | 140,000 | 782,690 | - | - | Common Stock | ||
| Janux Therapeutics Inc | Jay Lichter | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 54.75 per share. | 03 Jun 2024 | 131,196 | 633,673 | - | 54.8 | 7,182,981 | Common Stock |
| Janux Therapeutics Inc | Tighe Reardon | Acting Chief Financial Officer | 03 Jun 2024 | 131,196 | 633,673 | - | 54.8 | 7,182,981 | Common Stock | |
| Ingersoll Rand | Vicente Reynal | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 87.63 per share. | 03 Jun 2024 | 123,015 | 175,838 (0%) | 0% | 87.6 | 10,779,558 | Common Stock |
| Comtech Telecom Corp | Jeffery Paul Robertson | President, T&W Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 116,732 | 116,732 | - | - | Restricted Stock Units | |
| Callaway Golf Co | Brian P. Lynch | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 115,980 | 240,049 (0%) | 0% | 0 | Common Stock | |
| Callaway Golf Co | Brian P. Lynch | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 115,980 | 115,979 | - | - | Performance Stock Unit | |
| Golub Cap BDC Inc | William M. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 114,867 | 421,606 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Coherus Biosciences Inc | Mark D. Stolper | Director | 03 Jun 2024 | 112,000 | 112,000 | - | - | Stock Option (Right to Buy) | ||
| Coherus Biosciences Inc | Mats L. Wahlstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 112,000 | 112,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Kimberly J. Commins-Tzoumakas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 112,000 | 112,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Lee N. Newcomer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 112,000 | 112,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Charles Newton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 112,000 | 112,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Jill O’Donnell-Tormey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 112,000 | 112,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Michael Lee Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 112,000 | 112,000 | - | - | Stock Option (Right to Buy) | |
| Under Armour Inc (Class A) | David E. Bergman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 110,620 | 524,210 (0%) | 0% | 0 | Class C Common Stock | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 03 Jun 2024 | 106,200 | 191,907 | - | 0.3 | 36,108 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 03 Jun 2024 | 106,200 | 85,707 | - | 0 | Ordinary Shares | ||
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 106,200 | 213,800 | - | - | Share Option (right to buy) | |
| American Well Corp (Class A) | Robert Shepardson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.41 per share. | 03 Jun 2024 | 103,495 | 2,380,919 | - | 0.4 | 42,909 | Class A Common Stock |
| Relay Therapeutics Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 102,225 | 102,225 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Douglas S. Ingram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 102,225 | 102,225 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Linda A. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 102,225 | 102,225 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Mark Murcko | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 102,225 | 102,225 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Laura Shawver | Director | 03 Jun 2024 | 102,225 | 102,225 | - | - | Stock Option (Right to Buy) | ||
| Relay Therapeutics Inc | Jami Rubin | Director | 03 Jun 2024 | 102,225 | 102,225 | - | - | Stock Option (Right to Buy) | ||
| Relay Therapeutics Inc | Sekar Kathiresan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 102,225 | 102,225 | - | - | Stock Option (Right to Buy) | |
| Marqeta Inc (Class A) | Simon Khalaf | Director, Chief Executive Officer | 03 Jun 2024 | 101,361 | 1,114,972 | - | - | Restricted Stock Units | ||
| Marqeta Inc (Class A) | Simon Khalaf | Director, Chief Executive Officer | 03 Jun 2024 | 101,361 | 575,897 | - | 0 | Class A Common Stock | ||
| Kyndryl Holdings Inc | Elly Keinan | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 100,492 | 829,680 | - | 0 | Common Stock | |
| Amplitech Grp Inc | Fawad Maqbool | Director, Chairman, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 100,000 | 400,000 | - | - | Stock options (Right to buy) | |
| Distribution Soln Grp Inc | Cesar Lanuza | President and CEO | 03 Jun 2024 | 100,000 | 160,498 | - | - | Restricted Stock Units | ||
| Mangoceuticals Inc | Alex P. Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 100,000 | 175,000 | - | 0 | Common Stock | |
| Mangoceuticals Inc | Lorraine D’Alessio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 100,000 | 175,000 | - | 0 | Common Stock | |
| Mangoceuticals Inc | Kenny Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 100,000 | 175,000 | - | 0 | Common Stock | |
| Mangoceuticals Inc | Amanda Hammer | Chief Operating Officer | 03 Jun 2024 | 100,000 | 175,000 | - | 0 | Common Stock | ||
| Sable Offshore Corp | Pipkin Phillip Gregory | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 96,875 | 167,778 | - | 0 | Common Stock | |
| Marqeta Inc (Class A) | Simon Khalaf | Director, Chief Executive Officer | 03 Jun 2024 | 96,604 | 523,495 | - | 0 | Class A Common Stock | ||
| Marqeta Inc (Class A) | Simon Khalaf | Director, Chief Executive Officer | 03 Jun 2024 | 96,604 | 676,233 | - | - | Restricted Stock Units | ||
| Anika Therapeutics Inc | Stephen D. Griffin | EVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 96,525 | 96,525 | - | - | Stock Option (Right to Buy) | |
| Under Armour Inc (Class A) | Shawn Curran | Chief Supply Chain Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 92,183 | 167,886 (0%) | 0% | 0 | Class C Common Stock | |
| Under Armour Inc (Class A) | James A. Dausch | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 92,183 | 186,774 (0%) | 0% | 0 | Class C Common Stock | |
| Under Armour Inc (Class A) | Yassine Saidi | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 92,183 | 124,924 (0%) | 0% | 0 | Class C Common Stock | |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 90,230 | 0 | - | - | Performance Stock Unit | |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 90,230 | 90,230 (0%) | 0% | 0 | Common Stock | |
| Kratos Defense & Security Soln Inc | Yonah Adelman | President, ME Division | Sale of securities on an exchange or to another person at price $ 21.58 per share. | 03 Jun 2024 | 90,000 | 44,348 (0%) | 0% | 21.6 | 1,942,020 | Common Stock |
| Datadog Inc (Class A) | Olivier Pomel | Director, CHIEF EXECUTIVE OFFICER | 03 Jun 2024 | 85,637 | 423,229 (0%) | 0% | 0.3 | 26,265 | Class A Common Stock | |
| Datadog Inc (Class A) | Olivier Pomel | Director, CHIEF EXECUTIVE OFFICER | 03 Jun 2024 | 85,637 | 8,798,890 | - | - | Class B Common Stock | ||
| Information Services Grp Inc | Michael A. Sherrick | EVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 3.15 per share. | 03 Jun 2024 | 83,333 | 293,111 (0%) | 0% | 3.2 | 262,499 | Shares of Common Stock |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | 03 Jun 2024 | 82,762 | 185,759 (0%) | 0% | 0 | Class A Common Stock | ||
| Workday (Class A) | David A. Duffield | Ten Percent Owner | 03 Jun 2024 | 82,762 | 43,604,449 | - | - | Class B Common Stock | ||
| Dropbox Inc (Class A) | Andrew W. Houston | Director, Chief Executive Officer, Ten Percent Owner | 03 Jun 2024 | 82,000 | 82,000 (0%) | 0% | 0 | Class A Common Stock | ||
| Dropbox Inc (Class A) | Andrew W. Houston | Director, Chief Executive Officer, Ten Percent Owner | 03 Jun 2024 | 82,000 | 70,433,629 | - | - | Class B Common Stock | ||
| Dropbox Inc (Class A) | Andrew W. Houston | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 22.40 per share. | 03 Jun 2024 | 82,000 | 0 (0%) | 0% | 22.4 | 1,836,406 | Class A Common Stock |
| Comtech Telecom Corp | John Ratigan | Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 77,822 | 77,822 | - | - | Restricted Stock Units | |
| Bionano Genomics Inc | Mark Borodkin | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Alka Chaubey | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Gulsen Kama | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Gap Inc | Julie Gruber | Chief Legal&Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 74,252 | 46,168 | - | - | Non-Qualified Stock Option (right to buy) | |
| Gap Inc | Julie Gruber | Chief Legal&Compliance Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 03 Jun 2024 | 74,252 | 1,384 (0%) | 0% | 30 | 2,227,560 | Common Stock |
| Gap Inc | Julie Gruber | Chief Legal&Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 03 Jun 2024 | 74,252 | 75,636 (0%) | 0% | 6.3 | 466,303 | Common Stock |
| American Well Corp (Class A) | Phyllis Gotlib | President, International | Sale of securities on an exchange or to another person at price $ 0.41 per share. | 03 Jun 2024 | 71,455 | 2,383,655 | - | 0.4 | 29,625 | Class A Common Stock |
| B&G Foods Inc | Stephen C. Sherrill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 71,268 | 71,268 | - | - | Stock Option (Right to Buy) | |
| Coya Therapeutics Inc | David S. Snyder | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 70,596 | 70,596 | - | - | Stock Option (right to buy) | |
| Coya Therapeutics Inc | Fred Grossman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 70,596 | 70,596 | - | - | Stock Option (right to buy) | |
| Hims & Hers Health Inc (Class A) | Melissa Baird | Chief Operating Officer | 03 Jun 2024 | 70,506 | 634,402 | - | - | Stock Option (right to buy) | ||
| Hims & Hers Health Inc (Class A) | Melissa Baird | Chief Operating Officer | 03 Jun 2024 | 70,506 | 611,938 | - | 0.4 | 28,202 | Class A Common Stock | |
| Ralph Lauren | Ralph Lauren | Director, Exec. Chair, Chief Creative, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 70,234 | 967,701 (1%) | 0% | - | Class A Common Stock | |
| Under Armour Inc (Class A) | Kara Trent | President of the Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 70,059 | 173,889 (0%) | 0% | 0 | Class C Common Stock | |
| American Well Corp (Class A) | Kathy Johnson Weiler | Chief Comm. & Growth Officer | Sale of securities on an exchange or to another person at price $ 0.41 per share. | 03 Jun 2024 | 69,755 | 3,905,862 | - | 0.4 | 28,920 | Class A Common Stock |
| American Well Corp (Class A) | Kurt Knight | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.41 per share. | 03 Jun 2024 | 69,552 | 3,005,777 | - | 0.4 | 28,836 | Class A Common Stock |
| Kenvue | Russell Dyer | Chief Corp. Affairs Officer | 03 Jun 2024 | 68,389 | 68,389 | - | - | Stock Options | ||
| Bionano Genomics Inc | Jonathan V. Dixon | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 68,000 | 68,000 | - | - | Stock Option (Right to Buy) | |
| Datadog Inc (Class A) | Olivier Pomel | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 108.93 per share. | 03 Jun 2024 | 67,228 | 356,001 (0%) | 0% | 108.9 | 7,323,207 | Class A Common Stock |
| Korro Bio Inc | Olukemi Olugemo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Teva- pharma Ind Ltd (ADR) | Matthew Shields | EVP, Global Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 64,782 | 64,782 | - | - | Restricted Share Units | |
| Hims & Hers Health Inc (Class A) | Melissa Baird | Chief Operating Officer | 03 Jun 2024 | 64,406 | 547,532 | - | 20.3 | 1,308,730 | Class A Common Stock | |
| American Well Corp (Class A) | Vukasin Paunovich | EVP, Enterprise Platforms | 03 Jun 2024 | 62,810 | 2,469,089 | - | 0.4 | 26,041 | Class A Common Stock | |
| Under Armour Inc (Class A) | Mehri Shadman-Valavi | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 62,685 | 204,294 (0%) | 0% | 0 | Class C Common Stock | |
| Callaway Golf Co | Brian P. Lynch | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.68 per share. | 03 Jun 2024 | 62,607 | 177,442 (0%) | 0% | 15.7 | 981,678 | Common Stock |
| Allbirds Inc (Class A) | Annie Mitchell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.56 per share. | 03 Jun 2024 | 62,486 | 812,024 | - | 0.6 | 35,005 | Class A Common Stock |
| Procore Tech Inc | Craig F. Courtemanche | Director, CEO & President, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 66.10 per share. | 03 Jun 2024 | 59,592 | 2,620,618 | - | 66.1 | 3,939,031 | Common Stock |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 210.31 per share. | 03 Jun 2024 | 59,253 | 115,894 (0%) | 0% | 210.3 | 12,461,415 | Class A Common Stock |
| Allbirds Inc (Class A) | Joe Vernachio | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.56 per share. | 03 Jun 2024 | 58,510 | 918,087 | - | 0.6 | 32,777 | Class A Common Stock |
| Celldex Therapeutics Inc | Margo Heath-Chiozzi | SVP OF REGULATORY AFFAIRS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.38 per share. | 03 Jun 2024 | 58,369 | 71,752 (0%) | 0% | 10.4 | 605,870 | Common Stock |
| Celldex Therapeutics Inc | Margo Heath-Chiozzi | SVP OF REGULATORY AFFAIRS | Sale of securities on an exchange or to another person at price $ 33.65 per share. | 03 Jun 2024 | 58,369 | 13,383 (0%) | 0% | 33.6 | 1,964,088 | Common Stock |
| Celldex Therapeutics Inc | Margo Heath-Chiozzi | SVP OF REGULATORY AFFAIRS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 58,369 | 23,023 | - | - | Incentive Stock Option (Right to Buy) | |
| Owens & Minor Inc | Jennifer Stone | EVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 57,078 | 57,078 (0%) | 0% | 0 | Common Stock | |
| Ingersoll Rand | Vicente Reynal | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 90.22 per share. | 03 Jun 2024 | 56,817 | 135,491 (0%) | 0% | 90.2 | 5,126,143 | Common Stock |
| LivaNova PLC | Daniel Jeffrey Moore | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 56,623 | 0 | - | - | Option to purchase shares | |
| LivaNova PLC | Daniel Jeffrey Moore | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.39 per share. | 03 Jun 2024 | 56,623 | 84,157 (0%) | 0% | 57.4 | 3,249,594 | Ordinary Shares |
| Insmed Inc | S. Nicole Schaeffer | Chief People Strategy Officer | Sale of securities on an exchange or to another person at price $ 55.33 per share. | 03 Jun 2024 | 55,000 | 108,760 (0%) | 0% | 55.3 | 3,043,150 | Common Stock |
| LivaNova PLC | Daniel Jeffrey Moore | Director | Sale of securities on an exchange or to another person at price $ 60.07 per share. | 03 Jun 2024 | 54,578 | 29,579 (0%) | 0% | 60.1 | 3,278,773 | Ordinary Shares |
| Regional Management Corp | Robert William Beck | Director, President and CEO | 03 Jun 2024 | 53,191 | 53,191 | - | - | Restricted Stock Units | ||
| Kyndryl Holdings Inc | David B. Wyshner | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 52,891 | 567,643 | - | 0 | Common Stock | |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 51,546 | 308,299 (0%) | 0% | 0 | Common Stock | |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 51,546 | 0 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Simon Khalaf | Director, Chief Executive Officer | 03 Jun 2024 | 51,370 | 524,527 | - | 5.4 | 279,453 | Class A Common Stock | |
| Marqeta Inc (Class A) | Todd Pollak | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 50,367 | 239,193 | - | 0 | Class A Common Stock | |
| Marqeta Inc (Class A) | Todd Pollak | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 50,367 | 503,666 | - | - | Restricted Stock Units | |
| EVgo Inc (Class A) | Stephanie Lee | Interim CFO | 03 Jun 2024 | 50,000 | 50,000 | - | - | Restricted Stock Units | ||
| LoanDepot Inc (Class A) | Anthony Hsieh | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.81 per share. | 03 Jun 2024 | 50,000 | 2,856,605 (4%) | 0% | 1.8 | 90,265 | Class A Common Stock |
| Marqeta Inc (Class A) | Michael Milotich | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 49,759 | 547,350 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Michael Milotich | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 49,759 | 403,544 | - | 0 | Class A Common Stock | |
| Marqeta Inc (Class A) | Simon Khalaf | Director, Chief Executive Officer | 03 Jun 2024 | 48,959 | 474,536 | - | 5.4 | 266,337 | Class A Common Stock | |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.68 per share. | 03 Jun 2024 | 46,334 | 43,896 (0%) | 0% | 15.7 | 726,517 | Common Stock |
| Marqeta Inc (Class A) | Simon Khalaf | Director, Chief Executive Officer | 03 Jun 2024 | 44,391 | 449,389 | - | 0 | Class A Common Stock | ||
| Marqeta Inc (Class A) | Simon Khalaf | Director, Chief Executive Officer | 03 Jun 2024 | 44,391 | 355,124 | - | - | Restricted Stock Units | ||
| Ralph Lauren | Ralph Lauren | Director, Exec. Chair, Chief Creative, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 44,302 | 973,163 (1%) | 0% | - | Class A Common Stock | |
| Bionano Genomics Inc | R. Erik Holmlin | Director, PRESIDENT AND CEO | 03 Jun 2024 | 44,000 | 121,813 (0%) | 0% | 0 | Common Stock | ||
| GE Vernova | Scott L. Strazik | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 42,481 | 42,481 | - | - | Employee Stock Option (right to buy) | |
| Insmed Inc | S. Nicole Schaeffer | Chief People Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.76 per share. | 03 Jun 2024 | 41,250 | 163,760 (0%) | 0% | 22.8 | 938,850 | Common Stock |
| Insmed Inc | S. Nicole Schaeffer | Chief People Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 41,250 | 0 | - | - | Stock Option (right to buy) | |
| Relay Therapeutics Inc | Peter Rahmer | See remarks | Sale of securities on an exchange or to another person at price $ 6.64 per share. | 03 Jun 2024 | 40,595 | 452,875 | - | 6.6 | 269,551 | Common Stock |
| Monte Rosa Therapeutics Inc | Sharon Townson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Phil Nickson | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Jennifer Champoux | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Ingersoll Rand | Vicente Reynal | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 88.41 per share. | 03 Jun 2024 | 39,696 | 136,142 (0%) | 0% | 88.4 | 3,509,484 | Common Stock |
| Marqeta Inc (Class A) | Randall Kern | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 39,592 | 76,441 | - | 0 | Class A Common Stock | |
| Marqeta Inc (Class A) | Randall Kern | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 39,592 | 277,144 | - | - | Restricted Stock Units | |
| JFrog Ltd | Shlomi Ben Haim | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 31.15 per share. | 03 Jun 2024 | 38,924 | 5,105,649 | - | 31.2 | 1,212,483 | Ordinary Shares |
| Ralph Lauren | Ralph Lauren | Director, Exec. Chair, Chief Creative, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 185.63 per share. | 03 Jun 2024 | 38,840 | 928,861 (1%) | 0% | 185.6 | 7,210,063 | Class A Common Stock |
| Marqeta Inc (Class A) | Randall Kern | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 38,701 | 425,717 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Randall Kern | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 38,701 | 101,015 | - | 0 | Class A Common Stock | |
| Expensify Inc (Class A) | Anuradha Muralidharan | Director, Chief Operating Officer | 03 Jun 2024 | 38,638 | 96,897 | - | 0 | Class A Common Stock | ||
| Anika Therapeutics Inc | Stephen D. Griffin | EVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 38,520 | 38,520 | - | - | Restricted Stock Unit | |
| Vivid Seats Inc (Class A) | David A. Donnini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 38,167 | 38,167 | - | - | Restricted Stock Units | |
| Vivid Seats Inc (Class A) | Mark M. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 38,167 | 38,167 | - | - | Restricted Stock Units | |
| Vivid Seats Inc (Class A) | Jane E. DeFlorio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 38,167 | 38,167 | - | - | Restricted Stock Units | |
| Vivid Seats Inc (Class A) | Todd Boehly | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 38,167 | 38,167 | - | - | Restricted Stock Units | |
| Vivid Seats Inc (Class A) | Craig A. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 38,167 | 38,167 | - | - | Restricted Stock Units | |
| Vivid Seats Inc (Class A) | Tom Ehrhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 38,167 | 38,167 | - | - | Restricted Stock Units | |
| Vivid Seats Inc (Class A) | Julie D. Masino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 38,167 | 38,167 | - | - | Restricted Stock Units | |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 38,117 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 03 Jun 2024 | 38,117 | 85,922 | - | 1.1 | 42,310 | Common Stock |
| Callaway Golf Co | Rebecca A. Fine | EVP, Global CPO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 37,694 | 0 | - | - | Performance Stock Unit | |
| Callaway Golf Co | Rebecca A. Fine | EVP, Global CPO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 37,694 | 72,846 (0%) | 0% | 0 | Common Stock | |
| Marqeta Inc (Class A) | Crystal Sumner | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 36,858 | 405,445 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Crystal Sumner | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 36,858 | 116,506 | - | 0 | Class A Common Stock | |
| First Solar | Mark R. Widmar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 273.26 per share. | 03 Jun 2024 | 36,692 | 81,861 (0%) | 0% | 273.3 | 10,026,456 | Common Stock |
| Sera Prognostics Inc (Class A) | Joshua Phillips | Director | Other type of transaction at price $ 0.00 per share. | 03 Jun 2024 | 36,040 | 8 | - | 0 | Class A Common Stock | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | 03 Jun 2024 | 35,400 | 35,400 | - | - | American Depositary Shares | ||
| TriSalus Life Sciences Inc | Andrew C. von Eschenbach | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| TriSalus Life Sciences Inc | Andrew C. von Eschenbach | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| MetroCity Bankshares Inc | Nack Y. Paek | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 24.65 per share. | 03 Jun 2024 | 34,215 | 1,336,200 (5%) | 0% | 24.7 | 843,400 | Common Stock |
| MetroCity Bankshares Inc | Farid Tan | Director, President | Grant, award, or other acquisition of securities at price $ 24.65 per share. | 03 Jun 2024 | 34,215 | 954,888 (3%) | 0% | 24.7 | 843,400 | Common Stock |
| Weyerhaeuser | Brian Chaney | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 33,506 | 62,491 (0%) | 0% | 0 | Common | |
| Ingersoll Rand | Vicente Reynal | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 89.38 per share. | 03 Jun 2024 | 33,235 | 102,907 (0%) | 0% | 89.4 | 2,970,677 | Common Stock |
| Howmet Aerospace | Neil E. Marchuk | EVP, HR | Sale of securities on an exchange or to another person at price $ 84.26 per share. | 03 Jun 2024 | 32,614 | 217,687 (0%) | 0% | 84.3 | 2,748,124 | Common Stock |
| Golub Cap BDC Inc | William M. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 32,542 | 32,542 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Marqeta Inc (Class A) | Todd Pollak | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 32,251 | 354,764 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Todd Pollak | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 32,251 | 260,475 | - | 0 | Class A Common Stock | |
| Titan Machinery Inc | Bryan Knutson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 31,593 | 114,577 (0%) | 0% | 0 | Common Stock | |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 03 Jun 2024 | 31,186 | 74,035 | - | 1.1 | 34,616 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 31,186 | 38,117 | - | - | Non-Qualified Stock Option (right to buy) | |
| Principal Financial Group | Daniel J. Houston | Director, Chairman, President & CEO | 03 Jun 2024 | 30,675 | 179,527 (0%) | 0% | 0 | Common Stock | ||
| Ralph Lauren | Patrice Louvet | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 30,284 | 122,256 (0%) | 0% | - | Class A Common Stock | |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 30,000 | 30,000 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 30,000 | 201,667 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Roku Inc (Class A) | Charles Collier | President, Roku Media | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 29,340 | 293,398 | - | - | Restricted Stock Unit | |
| Roku Inc (Class A) | Charles Collier | President, Roku Media | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 29,340 | 37,814 (0%) | 0% | 0 | Class A Common Stock | |
| Courtside Grp Inc | D. Jonathan Merriman | Director | Purchase of securities on an exchange or from another person at price $ 1.86 per share. | 03 Jun 2024 | 28,839 | 28,839 | - | 1.9 | 53,641 | Common Stock, $0.00001 par value |
| nLIGHT Inc | Scott H. Keeney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.65 per share. | 03 Jun 2024 | 28,838 | 1,362,548 (3%) | 0% | 12.7 | 364,801 | Common Stock |
| Marqeta Inc (Class A) | Michael Milotich | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 28,670 | 200,688 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Michael Milotich | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 28,670 | 337,958 | - | 0 | Class A Common Stock | |
| Celldex Therapeutics Inc | Richard M. Wright | SR. VP & CCO | 03 Jun 2024 | 28,469 | 13,531 | - | - | Incentive Stock Option (right to buy) | ||
| Celldex Therapeutics Inc | Richard M. Wright | SR. VP & CCO | 03 Jun 2024 | 28,469 | 49,302 (0%) | 0% | 28 | 797,132 | Common Stock | |
| Information Services Grp Inc | Michael A. Sherrick | EVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 27,778 | 27,778 | - | - | Performance Based RSUs | |
| Celldex Therapeutics Inc | Richard M. Wright | SR. VP & CCO | 03 Jun 2024 | 27,580 | 40,097 (0%) | 0% | 33.5 | 924,658 | Common Stock | |
| Ingredion Inc | James P. Zallie | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 27,500 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Ingredion Inc | James P. Zallie | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 116.36 per share. | 03 Jun 2024 | 27,500 | 52,196 (0%) | 0% | 116.4 | 3,199,873 | Common Stock |
| Ingredion Inc | James P. Zallie | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 82.28 per share. | 03 Jun 2024 | 27,500 | 79,696 (0%) | 0% | 82.3 | 2,262,700 | Common Stock |
| Rumble Inc (Class A) | Robert Arsov | Director | 03 Jun 2024 | 27,500 | 15,113,902 | - | 6.0 | 164,725 | Class A Common Stock, par value $0.0001 per share | |
| Rumble Inc (Class A) | Robert Arsov | Director | 03 Jun 2024 | 27,500 | 15,143,902 | - | 6.1 | 168,025 | Class A Common Stock, par value $0.0001 per share | |
| Marqeta Inc (Class A) | Crystal Sumner | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 27,318 | 93,493 | - | 0 | Class A Common Stock | |
| Marqeta Inc (Class A) | Crystal Sumner | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 27,318 | 300,504 | - | - | Restricted Stock Units | |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 27,000 | 231,667 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Old Republic Intl Corp | Carolyn Monroe | SVP - Title Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 26,640 | 26,720 | - | - | 2022 Employee Stock Option | |
| Old Republic Intl Corp | Carolyn Monroe | SVP - Title Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.92 per share. | 03 Jun 2024 | 26,640 | 60,196 (0%) | 0% | 22.9 | 610,589 | Common Stock |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.68 per share. | 03 Jun 2024 | 26,469 | 281,830 (0%) | 0% | 15.7 | 415,034 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 3.80 per share. | 03 Jun 2024 | 26,230 | 47,805 | - | 3.8 | 99,766 | Common Stock |
| Recursion Pharma Inc (Class A) | Robert M. Hershberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 26,193 | 26,193 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Terry-Ann Burrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 26,193 | 26,193 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Blake Borgeson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 26,193 | 26,193 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Zavain Dar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 26,193 | 26,193 | - | - | Stock Option (Right to Buy) | |
| Arcturus Therapeutics Holdings Inc | Padmanabh Chivukula | Chief Scientific Officer & COO | Sale of securities on an exchange or to another person at price $ 40.01 per share. | 03 Jun 2024 | 26,000 | 447,448 (2%) | 0% | 40.0 | 1,040,234 | Common Stock |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 184.96 per share. | 03 Jun 2024 | 25,911 | 258,667 (0%) | 0% | 185.0 | 4,792,499 | Common Stock, $0.01 par value |
| MetroCity Bankshares Inc | Howard Hwasaeng Kim | Director, Executive Vice President | Grant, award, or other acquisition of securities at price $ 24.65 per share. | 03 Jun 2024 | 25,754 | 597,244 (2%) | 0% | 24.6 | 634,836 | Common Stock |
| Walmart | John David Rainey | Executive Vice President | Sale of securities on an exchange or to another person at price $ 65.48 per share. | 03 Jun 2024 | 25,578 | 415,743 (0%) | 0% | 65.5 | 1,674,934 | Common |
| Marqeta Inc (Class A) | Michael Milotich | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 25,406 | 350,871 | - | 0 | Class A Common Stock | |
| Marqeta Inc (Class A) | Michael Milotich | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 25,406 | 177,846 | - | - | Restricted Stock Units | |
| Alector Inc | Arnon Rosenthal | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.80 per share. | 03 Jun 2024 | 25,135 | 1,975,245 (2%) | 0% | 4.8 | 120,618 | Common Stock |
| Callaway Golf Co | Mark F. Lepoksy | EVP,Chief Supply Chain Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 25,130 | 317,862 (0%) | 0% | 0 | Common Stock | |
| Callaway Golf Co | Mark F. Lepoksy | EVP,Chief Supply Chain Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 25,130 | 0 | - | - | Performance Stock Unit | |
| Callaway Golf Co | Glenn F. Hickey | EVP & Pres., Callaway Golf | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 25,130 | 0 | - | - | Performance Stock Unit | |
| Callaway Golf Co | Glenn F. Hickey | EVP & Pres., Callaway Golf | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 25,130 | 86,234 (0%) | 0% | 0 | Common Stock | |
| SES AI Corp (Class A) | Hong Gan | CHIEF SCIENCE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 25,000 | 268,277 | - | - | Stock Option (Right to Buy) | |
| SES AI Corp (Class A) | Hong Gan | CHIEF SCIENCE OFFICER | Sale of securities on an exchange or to another person at price $ 1.25 per share. | 03 Jun 2024 | 25,000 | 825,506 | - | 1.2 | 31,153 | Class A Common Stock |
| SES AI Corp (Class A) | Hong Gan | CHIEF SCIENCE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.15 per share. | 03 Jun 2024 | 25,000 | 850,506 | - | 0.2 | 3,750 | Class A Common Stock |
| OSI Systems Inc | Alan I. Edrick | EVP & CFO | Sale of securities on an exchange or to another person at price $ 143.70 per share. | 03 Jun 2024 | 25,000 | 315,915 (1%) | 0% | 143.7 | 3,592,500 | Common Stock |
| Expensify Inc (Class A) | Jason Mills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 24,789 | 221,449 | - | 0 | Class A Common Stock | |
| Titan Machinery Inc | Robert J. Larsen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 24,725 | 41,132 (0%) | 0% | 0 | Common Stock | |
| SiriusPoint Ltd | James J. McKinney | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 24,704 | 24,704 (0%) | 0% | 0 | Common Shares | |
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 21.27 per share. | 03 Jun 2024 | 24,700 | 9,300 | - | 21.3 | 525,455 | Class A Common Stock |
| AlTi Global Inc (Class A) | Michael Tiedemann | Director, Chief Executive Officer | 03 Jun 2024 | 24,652 | 499,886 | - | 4.9 | 119,809 | Class A Common Stock | |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 24,608 | 0 | - | - | Restricted Stock Units | |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 24,608 | 79,917 (0%) | 0% | 0 | Common Stock | |
| Brighthouse Fin Inc | Eric T. Steigerwalt | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 44.37 per share. | 03 Jun 2024 | 24,600 | 346,472 (0%) | 0% | 44.4 | 1,091,502 | Common Stock |
| Collegium pharma Inc | Shirley R. Kuhlmann | EVP and General Counsel | 03 Jun 2024 | 24,300 | 140,109 (0%) | 0% | 32.5 | 790,926 | Common Stock | |
| Marqeta Inc (Class A) | Michael Milotich | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 23,755 | 166,287 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Michael Milotich | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 23,755 | 363,787 | - | 0 | Class A Common Stock | |
| Ralph Lauren | Ralph Lauren | Director, Exec. Chair, Chief Creative, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 185.63 per share. | 03 Jun 2024 | 23,692 | 949,471 (1%) | 0% | 185.6 | 4,398,064 | Class A Common Stock |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 23,460 | 0 | - | - | Performance Stock Unit | |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 23,460 | 67,356 (0%) | 0% | 0 | Common Stock | |
| Marqeta Inc (Class A) | Michael Milotich | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.44 per share. | 03 Jun 2024 | 23,181 | 380,363 | - | 5.4 | 126,105 | Class A Common Stock |
| Liberty Energy Inc (Class A) | Ken Babcock | Director | Sale of securities on an exchange or to another person at price $ 23.66 per share. | 03 Jun 2024 | 23,133 | 59,289 (0%) | 0% | 23.7 | 547,234 | Class A Common Stock |
| Coinbase Global Inc (Class A) | Brian Armstrong | Director, Chairman and CEO, Ten Percent Owner | 03 Jun 2024 | 23,075 | 23,601 | - | 0 | Class A Common Stock | ||
| Coinbase Global Inc (Class A) | Brian Armstrong | Director, Chairman and CEO, Ten Percent Owner | 03 Jun 2024 | 23,075 | 25,810,050 | - | - | Class B Common Stock | ||
| Kyndryl Holdings Inc | Vineet Khurana | SVP & Global Controller | 03 Jun 2024 | 22,930 | 22,931 | - | - | Employee Stock Option (Right to Buy) | ||
| Kyndryl Holdings Inc | Vineet Khurana | SVP & Global Controller | 03 Jun 2024 | 22,930 | 78,722 | - | 26.4 | 604,244 | Common Stock | |
| Kyndryl Holdings Inc | Vineet Khurana | SVP & Global Controller | 03 Jun 2024 | 22,930 | 101,652 | - | 17.8 | 407,695 | Common Stock | |
| AlTi Global Inc (Class A) | Michael Tiedemann | Director, Chief Executive Officer | 03 Jun 2024 | 22,721 | 475,234 | - | 4.9 | 110,651 | Class A Common Stock | |
| Equinix Inc | Adaire Fox-Martin | CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 22,581 | 22,581 | - | - | Restricted Stock Unit | |
| Marqeta Inc (Class A) | Simon Khalaf | Director, Chief Executive Officer | 03 Jun 2024 | 22,498 | 426,891 | - | 5.4 | 122,389 | Class A Common Stock | |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 22,467 | 99,018 (0%) | 0% | 0 | Common Stock | |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 22,467 | 44,933 | - | - | Restricted Stock Units | |
| Old Republic Intl Corp | Carolyn Monroe | SVP - Title Insurance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.78 per share. | 03 Jun 2024 | 22,137 | 38,059 (0%) | 0% | 31.8 | 703,514 | Common Stock |
| Cabaletta Bio Inc | Richard C. Henriques | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Catherine Bollard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Scott C. Brun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Crocs Inc | Susan L. Healy | EVP, Chief Financial Officer | 03 Jun 2024 | 21,652 | 21,652 (0%) | 0% | 0 | Common Stock | ||
| Viatris | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 21,267 | 21,267 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Todd Pollak | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.44 per share. | 03 Jun 2024 | 21,154 | 218,039 | - | 5.4 | 115,078 | Class A Common Stock |
| Expensify Inc (Class A) | Anuradha Muralidharan | Director, Chief Operating Officer | 03 Jun 2024 | 21,118 | 58,259 | - | 1.4 | 30,199 | Class A Common Stock | |
| Wendy`s Co (Class A) | Kristin A. Dolan | Director | 03 Jun 2024 | 21,000 | 39,478 (0%) | 0% | 17.4 | 365,182 | Common Stock | |
| Vivid Seats Inc (Class A) | David A. Donnini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 20,833 | 48,690 | - | - | Class A Common Stock | |
| Vivid Seats Inc (Class A) | David A. Donnini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 20,833 | 0 | - | - | Restricted Stock Units | |
| Vivid Seats Inc (Class A) | Mark M. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 20,833 | 48,690 | - | - | Class A Common Stock | |
| Vivid Seats Inc (Class A) | Mark M. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 20,833 | 0 | - | - | Restricted Stock Units | |
| Vivid Seats Inc (Class A) | Jane E. DeFlorio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 20,833 | 0 | - | - | Restricted Stock Units | |
| Vivid Seats Inc (Class A) | Jane E. DeFlorio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 20,833 | 76,690 | - | - | Class A Common Stock | |
| Vivid Seats Inc (Class A) | Todd Boehly | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 20,833 | 48,690 | - | - | Class A Common Stock | |
| Vivid Seats Inc (Class A) | Todd Boehly | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 20,833 | 0 | - | - | Restricted Stock Units | |
| Vivid Seats Inc (Class A) | Craig A. Dixon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 20,833 | 31,301 | - | - | Class A Common Stock | |
| Vivid Seats Inc (Class A) | Craig A. Dixon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 20,833 | 0 | - | - | Restricted Stock Units | |
| Vivid Seats Inc (Class A) | Tom Ehrhart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 20,833 | 48,690 | - | - | Class A Common Stock | |
| Vivid Seats Inc (Class A) | Tom Ehrhart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 20,833 | 0 | - | - | Restricted Stock Units | |
| Vivid Seats Inc (Class A) | Julie D. Masino | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 20,833 | 48,690 | - | - | Class A Common Stock | |
| Vivid Seats Inc (Class A) | Julie D. Masino | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 20,833 | 0 | - | - | Restricted Stock Units | |
| Magnite Inc | David L. Day | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 03 Jun 2024 | 20,732 | 471,131 (0%) | 0% | 13 | 269,516 | Common Stock |
| Celldex Therapeutics Inc | Richard M. Wright | SR. VP & CCO | 03 Jun 2024 | 20,625 | 20,833 (0%) | 0% | 2.8 | 57,338 | Common Stock | |
| Celldex Therapeutics Inc | Richard M. Wright | SR. VP & CCO | 03 Jun 2024 | 20,625 | 0 | - | - | Incentive Stock Option (right to buy) | ||
| ORIC Pharma Inc | Lori Anne Kunkel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 20,500 | 33,200 | - | - | Stock Option (right to buy) | |
| ORIC Pharma Inc | Lori Anne Kunkel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.75 per share. | 03 Jun 2024 | 20,500 | 20,500 | - | 3.8 | 76,875 | Common Stock |
| Relay Therapeutics Inc | Peter Rahmer | See remarks | Sale of securities on an exchange or to another person at price $ 7.06 per share. | 03 Jun 2024 | 20,450 | 432,425 | - | 7.1 | 144,377 | Common Stock |
| JFrog Ltd | Tali Notman | CHIEF REVENUE OFFICER | 03 Jun 2024 | 20,308 | 593,782 | - | 31.1 | 632,594 | Ordinary Shares | |
| Whitehawk Therapeutics Inc | Neil P. Desai | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 1.77 per share. | 03 Jun 2024 | 20,225 | 1,291,543 | - | 1.8 | 35,746 | Common Stock |
| Futurefuel Corp | Thomas Mckinlay | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.38 per share. | 03 Jun 2024 | 20,000 | 40,000 (0%) | 0% | 4.4 | 87,600 | Common Stock |
| Liberty Energy Inc (Class A) | Michael Stock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 24.32 per share. | 03 Jun 2024 | 20,000 | 805,207 (0%) | 0% | 24.3 | 486,330 | Class A Common Stock |
| ANI Pharma Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 64.41 per share. | 03 Jun 2024 | 20,000 | 213,226 (1%) | 0% | 64.4 | 1,288,200 | Common Stock |
| Liberty Energy Inc (Class A) | Christopher A. Wright | Director, Chairman of the Board and CEO | 03 Jun 2024 | 20,000 | 2,778,813 (3%) | 0% | 22.8 | 455,200 | Class A Common Stock | |
| Courtside Grp Inc | D. Jonathan Merriman | Director | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 03 Jun 2024 | 20,000 | 163,079 | - | 2 | 40,000 | Common Stock, $0.00001 par value |
| Netflix | Reed Hastings | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 19,943 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Netflix | Reed Hastings | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.69 per share. | 03 Jun 2024 | 19,943 | 20,000 (0%) | 0% | 62.7 | 1,250,141 | Common Stock |
| Relay Therapeutics Inc | Peter Rahmer | See remarks | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 03 Jun 2024 | 19,864 | 493,470 | - | 6.5 | 128,520 | Common Stock |
| Kyndryl Holdings Inc | Edward Sebold | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 19,834 | 162,360 | - | 0 | Common Stock | |
| Whitehawk Therapeutics Inc | Neil P. Desai | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 1.81 per share. | 03 Jun 2024 | 19,775 | 1,311,768 | - | 1.8 | 35,765 | Common Stock |
| Forrester Research Inc | Jobina Gonsalves | Chief People Officer | 03 Jun 2024 | 19,651 | 19,651 | - | - | Restricted Stock Units | ||
| Celldex Therapeutics Inc | Richard M. Wright | SR. VP & CCO | 03 Jun 2024 | 19,264 | 20,833 (0%) | 0% | 34.0 | 654,695 | Common Stock | |
| Therealreal Inc | Rati Sahi Levesque | President | Sale of securities on an exchange or to another person at price $ 2.61 per share. | 03 Jun 2024 | 19,250 | 1,237,613 (1%) | 0% | 2.6 | 50,212 | Common Stock |
| Liberty Energy Inc (Class A) | Christopher A. Wright | Director, Chairman of the Board and CEO | 03 Jun 2024 | 19,217 | 2,799,596 (3%) | 0% | 23.5 | 452,176 | Class A Common Stock | |
| AvePoint Inc (Class A) | Jeffrey E. Epstein | Director | Grant, award, or other acquisition of securities at price $ 9.12 per share. | 03 Jun 2024 | 19,189 | 1,140,247 | - | 9.1 | 175,004 | Common Stock |
| AvePoint Inc (Class A) | Janet Schijns | Director | Grant, award, or other acquisition of securities at price $ 9.12 per share. | 03 Jun 2024 | 19,189 | 80,057 | - | 9.1 | 175,004 | Common Stock |
| AvePoint Inc (Class A) | Jeff Teper | Director | Grant, award, or other acquisition of securities at price $ 9.12 per share. | 03 Jun 2024 | 19,189 | 300,560 | - | 9.1 | 175,004 | Common Stock |
| AvePoint Inc (Class A) | John Ho | Director | Grant, award, or other acquisition of securities at price $ 9.12 per share. | 03 Jun 2024 | 19,189 | 4,312,545 | - | 9.1 | 175,004 | Common Stock |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 19,058 | 86,338 (0%) | 0% | 0 | Common Stock | |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 19,058 | 19,057 | - | - | Restricted Stock Units | |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 18,834 | 301,620 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Mercer Intl Inc | William D. McCartney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 18,816 | 18,816 | - | - | Deferred Stock Units | |
| Marqeta Inc (Class A) | Crystal Sumner | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.44 per share. | 03 Jun 2024 | 18,680 | 97,826 | - | 5.4 | 101,619 | Class A Common Stock |
| Celldex Therapeutics Inc | Richard M. Wright | SR. VP & CCO | 03 Jun 2024 | 18,375 | 23,625 | - | - | Incentive Stock Option (right to buy) | ||
| Celldex Therapeutics Inc | Richard M. Wright | SR. VP & CCO | 03 Jun 2024 | 18,375 | 67,677 (0%) | 0% | 22.5 | 413,070 | Common Stock | |
| Vaxcyte Inc | Halley E. Gilbert | Director | Sale of securities on an exchange or to another person at price $ 73.00 per share. | 03 Jun 2024 | 18,200 | 5,625 | - | 73 | 1,328,600 | Common Stock |
| Vaxcyte Inc | Halley E. Gilbert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 03 Jun 2024 | 18,200 | 23,825 | - | 5.4 | 97,370 | Common Stock |
| Vaxcyte Inc | Halley E. Gilbert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 18,200 | 30,374 | - | - | Stock Option (Right to Buy) | |
| Ralph Lauren | Patrice Louvet | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 18,038 | 124,833 (0%) | 0% | - | Class A Common Stock | |
| MiNK Therapeutics Inc | Brian J. Corvese | Director | Grant, award, or other acquisition of securities at price $ 0.99 per share. | 03 Jun 2024 | 17,967 | 383,494 | - | 1.0 | 17,787 | Common Stock |
| AST SpaceMobile Inc (Class A) | Johan Wibergh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 17,899 | 17,899 | - | 0 | Class A Common Stock | |
| Ardelyx Inc | David P. Rosenbaum | Chief Development Officer | 03 Jun 2024 | 17,872 | 158,502 (0%) | 0% | 7 | 125,104 | Common Stock | |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.99 per share. | 03 Jun 2024 | 17,841 | 104,458 | - | 1.0 | 17,663 | Common Stock |
| Ingersoll Rand | Vicente Reynal | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 92.33 per share. | 03 Jun 2024 | 17,745 | 101,117 (0%) | 0% | 92.3 | 1,638,360 | Common Stock |
| Roku Inc (Class A) | Dan Jedda | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 17,726 | 51,493 (0%) | 0% | 0 | Class A Common Stock | |
| Roku Inc (Class A) | Dan Jedda | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 17,726 | 212,714 | - | - | Restricted Stock Unit | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Jun 2024 | 17,700 | 0 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Xichen Lin | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Jun 2024 | 17,700 | 17,700 | - | - | American Depositary Shares | |
| Hims & Hers Health Inc (Class A) | Melissa Baird | Chief Operating Officer | 03 Jun 2024 | 17,625 | 616,777 | - | - | Stock Option (right to buy) | ||
| Hims & Hers Health Inc (Class A) | Melissa Baird | Chief Operating Officer | 03 Jun 2024 | 17,625 | 599,152 | - | - | Stock Option (right to buy) | ||
| Hims & Hers Health Inc (Class A) | Melissa Baird | Chief Operating Officer | 03 Jun 2024 | 17,625 | 559,057 | - | 0.4 | 7,050 | Class A Common Stock | |
| Hims & Hers Health Inc (Class A) | Melissa Baird | Chief Operating Officer | 03 Jun 2024 | 17,625 | 559,057 | - | 0.4 | 7,050 | Class A Common Stock | |
| Keros Therapeutics Inc | Jean-Jacques Bienaime | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 17,600 | 17,600 | - | - | Stock Option (right to buy) | |
| RBC Bearings Inc | Michael J. Hartnett | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 295.28 per share. | 03 Jun 2024 | 17,575 | 293,039 (1%) | 0% | 295.3 | 5,189,546 | Common Stock |
| Expensify Inc (Class A) | Anuradha Muralidharan | Director, Chief Operating Officer | 03 Jun 2024 | 17,520 | 79,377 | - | 1.5 | 26,280 | Class A Common Stock | |
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 03 Jun 2024 | 17,288 | 34,000 | - | 0 | Class A Common Stock | ||
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 17,288 | 620,187 | - | - | Stock Option (Right to buy Class B Common Stock) | |
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 17,288 | 228,272 | - | - | Class B Common Stock | |
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 03 Jun 2024 | 17,288 | 210,984 | - | - | Class B Common Stock | ||
| Callaway Golf Co | Brian P. Lynch | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 17,182 | 194,624 (0%) | 0% | 0 | Common Stock | |
| Callaway Golf Co | Brian P. Lynch | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 17,182 | 0 | - | - | Restricted Stock Units | |
| Expensify Inc (Class A) | David Barrett | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.44 per share. | 03 Jun 2024 | 17,060 | 680,957 | - | 1.4 | 24,566 | Class A Common Stock |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 184.96 per share. | 03 Jun 2024 | 17,042 | 284,578 (0%) | 0% | 185.0 | 3,152,088 | Common Stock, $0.01 par value |
| Datadog Inc (Class A) | Olivier Pomel | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 109.72 per share. | 03 Jun 2024 | 17,009 | 338,992 (0%) | 0% | 109.7 | 1,866,224 | Class A Common Stock |
| Expensify Inc (Class A) | David Barrett | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.46 per share. | 03 Jun 2024 | 16,910 | 714,862 | - | 1.5 | 24,689 | Class A Common Stock |
| Expensify Inc (Class A) | David Barrett | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.46 per share. | 03 Jun 2024 | 16,845 | 698,017 | - | 1.5 | 24,594 | Class A Common Stock |
| Funko Inc (Class A) | Andrew David Oddie | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 9.22 per share. | 03 Jun 2024 | 16,690 | 57,091 (0%) | 0% | 9.2 | 153,822 | CLASS A COMMON STOCK |
| Levi Strauss & Co. - Ordinary Shares Cls A | David A. Friedman | Director | 03 Jun 2024 | 16,666 | 166,676 (0%) | 0% | 23.9 | 398,984 | Class A Common Stock | |
| Ingersoll Rand | Vicente Reynal | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 91.49 per share. | 03 Jun 2024 | 16,629 | 118,862 (0%) | 0% | 91.5 | 1,521,437 | Common Stock |
| Bionano Genomics Inc | Mark Borodkin | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 16,000 | 64,698 (0%) | 0% | 0 | Common Stock | |
| Bionano Genomics Inc | Alka Chaubey | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 16,000 | 48,245 (0%) | 0% | 0 | Common Stock | |
| Bionano Genomics Inc | Gulsen Kama | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 16,000 | 16,000 (0%) | 0% | 0 | Common Stock | |
| FirstEnergy | Brian X. Tierney | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.62 per share. | 03 Jun 2024 | 15,959 | 198,280 (0%) | 0% | 39.6 | 632,296 | Common Stock |
| Iron Mountain | William L. Meaney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 80.38 per share. | 03 Jun 2024 | 15,875 | 295,650 (0%) | 0% | 80.4 | 1,276,033 | Common Stock, par value $.01 per share |
| Iron Mountain | William L. Meaney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 15,875 | 190,497 | - | - | Employee Stock Option (Right to Buy) | |
| Iron Mountain | William L. Meaney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 15,875 | 206,372 | - | - | Employee Stock Option (Right to Buy) | |
| Iron Mountain | William L. Meaney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.54 per share. | 03 Jun 2024 | 15,875 | 311,525 (0%) | 0% | 48.5 | 770,541 | Common Stock, par value $.01 per share |
| Iron Mountain | William L. Meaney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.54 per share. | 03 Jun 2024 | 15,875 | 311,525 (0%) | 0% | 48.5 | 770,541 | Common Stock, par value $.01 per share |
| Iron Mountain | William L. Meaney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 81.03 per share. | 03 Jun 2024 | 15,875 | 295,650 (0%) | 0% | 81.0 | 1,286,351 | Common Stock, par value $.01 per share |
| Marqeta Inc (Class A) | Todd Pollak | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 15,836 | 110,858 | - | - | Restricted Stock Units | |
| Marqeta Inc (Class A) | Todd Pollak | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 15,836 | 233,875 | - | 0 | Class A Common Stock | |
| Palo Alto | Nir Zuk | Director, EVP, Chief Technology Officer | 03 Jun 2024 | 15,830 | 1,273,101 (1%) | 0% | 292.9 | 4,635,847 | Common Stock | |
| Regional Management Corp | Harpreet Rana | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 15,780 | 41,634 (0%) | 0% | 0 | Common Stock | |
| Expensify Inc (Class A) | Daniel Vidal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 15,617 | 151,550 | - | 0 | Class A Common Stock | |
| Ralph Lauren | Patrice Louvet | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 185.64 per share. | 03 Jun 2024 | 15,461 | 106,795 (0%) | 0% | 185.6 | 2,870,103 | Class A Common Stock |
| MiNK Therapeutics Inc | Peter Behner | Director | Grant, award, or other acquisition of securities at price $ 0.99 per share. | 03 Jun 2024 | 15,454 | 90,481 | - | 1.0 | 15,299 | Common Stock |
| Simulations Plus Inc | Walter S. Woltosz | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.00 per share. | 03 Jun 2024 | 15,391 | 3,565,466 (20%) | 0% | 46 | 707,986 | Common Stock |
| Pulmonx Corp | Dana G. Mead | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 15,216 | 62,561 | - | 0 | Common Stock | |
| Pulmonx Corp | Daniel P. Florin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 15,216 | 40,968 | - | 0 | Common Stock | |
| Pulmonx Corp | Thomas W. Burns | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 15,216 | 36,246 | - | 0 | Common Stock | |
| Pulmonx Corp | Georgia Garinois-Melenikiotou | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 15,216 | 62,561 | - | 0 | Common Stock | |
| Pulmonx Corp | Glendon E. French | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 15,216 | 1,131,974 | - | 0 | Common Stock | |
| Pulmonx Corp | Richard Ferrari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 15,216 | 57,871 | - | 0 | Common Stock | |
| Pulmonx Corp | Tiffany Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 15,216 | 38,046 | - | 0 | Common Stock | |
| Baxter International | Christopher A. Toth | EVP,Group Pres, Kidney Care | 03 Jun 2024 | 15,202 | 213,282 (0%) | 0% | 34.1 | 518,084 | Common Stock, $1 par value | |
| Expensify Inc (Class A) | Ryan Schaffer | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 15,121 | 137,842 | - | 0 | Class A Common Stock | |
| MiNK Therapeutics Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.99 per share. | 03 Jun 2024 | 15,077 | 105,410 | - | 1.0 | 14,926 | Common Stock |
| Callaway Golf Co | Brian P. Lynch | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 15,038 | 120,703 (0%) | 0% | 0 | Common Stock | |
| Callaway Golf Co | Brian P. Lynch | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 15,038 | 0 | - | - | Performance Stock Unit |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.